| Metric | Q2 2025 | Q1 2025 | Q2 2024 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $2.1B | $2.0B | $2.0B | 7.0% | 8.9% |
| Op. Income | $742M | $730M | $546M | 1.7% | 35.8% |
| Gross Margin | 74.6% | 72.5% | 62.4% | 2.1pp | 12.2pp |
| Net Margin | 24.6% | 25.6% | 19.7% | -1.1pp | 4.9pp |
| EPS (Diluted) | $6.60 | $6.49 | $4.88 | 1.8% | 35.4% |
| Free Cash Flow | $1.7B | $247M | $0 | 606.7% | — |
| Item | Amount |
|---|---|
| REVENUE | $2.1B |
| Cost of Revenue | $545M |
| GROSS PROFIT | $1.6B |
| R&D Expenses | $0 |
| Selling & Marketing | $32M |
| General & Administrative | $553M |
| SG&A Expenses | $586M |
| Other Expenses | $276M |
| Operating Expenses | $861M |
| Cost & Expenses | $1.4B |
| OPERATING INCOME | $742M |
| Interest Income | $1.4B |
| Interest Expense | $378M |
| Other Income/Expenses | $0 |
| INCOME BEFORE TAX | $742M |
| Income Tax Expense | $202M |
| NET INCOME | $528M |
| D&A | $62M |
| EBIT | $742M |
| EBITDA | $803M |
| EPS | $7 |
| EPS Diluted | $7 |
| Item | Amount |
|---|---|
| REVENUE | $2.1B |
| Cost of Revenue | $545M |
| GROSS PROFIT | $1.6B |
| R&D Expenses | $0 |
| Selling & Marketing | $32M |
| General & Administrative | $553M |
| SG&A Expenses | $586M |
| Other Expenses | $276M |
| Operating Expenses | $861M |
| Cost & Expenses | $1.4B |
| OPERATING INCOME | $742M |
| Interest Income | $1.4B |
| Interest Expense | $378M |
| Other Income/Expenses | $0 |
| INCOME BEFORE TAX | $742M |
| Income Tax Expense | $202M |
| NET INCOME | $528M |
| D&A | $62M |
| EBIT | $742M |
| EBITDA | $803M |
| EPS | $7 |
| EPS Diluted | $7 |
| Item | Amount |
|---|---|
| Net Income | $528M |
| Depreciation & Amortization | $62M |
| Stock-Based Compensation | $0 |
| Deferred Income Tax | $0 |
| Other Non-Cash Items | $280M |
| Change in Working Capital | $889M |
| OPERATING CASH FLOW | $1.8B |
| Capital Expenditure | -$15M |
| Acquisitions (Net) | $275M |
| Purchases of Investments | $0 |
| Sales/Maturities of Investments | $0 |
| Other Investing Activities | -$369M |
| NET CASH FROM INVESTING | -$109M |
| Net Debt Issuance | -$178M |
| Common Stock Repurchased | $0 |
| Common Dividends Paid | -$953M |
| Other Financing Activities | -$1.1B |
| NET CASH FROM FINANCING | -$2.2B |
| FREE CASH FLOW | $1.7B |
| Net Change in Cash | -$880M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $12.0B |
| Short-Term Investments | $11.0B |
| Net Receivables | $0 |
| Inventory | $0 |
| Other Current Assets | $0 |
| TOTAL CURRENT ASSETS | $23.0B |
| PP&E (Net) | $766M |
| Goodwill | $490M |
| Intangible Assets | $769M |
| Long-Term Investments | $42.9B |
| Tax Assets | $0 |
| Other Non-Current Assets | $4.3B |
| TOTAL NON-CURRENT ASSETS | $49.1B |
| TOTAL ASSETS | $72.1B |
| Account Payables | $223M |
| Short-Term Debt | $3.3B |
| Deferred Revenue | $0 |
| Other Current Liabilities | $44.8B |
| TOTAL CURRENT LIABILITIES | $48.3B |
| Long-Term Debt | $6.7B |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $0 |
| Other Non-Current Liabilities | $6.9B |
| TOTAL NON-CURRENT LIABILITIES | $13.6B |
| TOTAL LIABILITIES | $62.0B |
| Common Stock | $382M |
| Additional Paid-In Capital | $39M |
| Retained Earnings | $1.0B |
| Treasury Stock | -$61M |
| Accum. Other Comp. Income | $8.6B |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $10.0B |
| Minority Interest | $178M |
| TOTAL EQUITY | $10.2B |
| TOTAL LIABILITIES & EQUITY | $72.1B |
| Total Debt | $10.0B |
| Net Debt | -$2.0B |
